{
    "Trade/Device Name(s)": [
        "VALIDATE\u00ae SP1 Calibration Verification Test Set"
    ],
    "Submitter Information": "Maine Standards Company",
    "510(k) Number": "K072246",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031575",
        "K031577"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "August 08, 2007",
    "Summary Letter Received Date": "August 13, 2007",
    "Submission Date": "August 01, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Immunoglobulin A",
        "Immunoglobulin G",
        "Immunoglobulin M",
        "Complement C3",
        "Complement C4",
        "a1-Antitrypsin",
        "Transferrin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        ""
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Calibration Verification Test Set",
        "Quality control material",
        "Reference Material"
    ],
    "Document Summary": "FDA 510(k) summary for VALIDATE\u00ae SP1 Calibration Verification Test Set, an assayed/unassayed human serum calibration verifier for immunoproteins and complement analytes",
    "Indications for Use Summary": "Intended for in vitro diagnostic use to determine linearity, calibration verification, and reportable range verification for IgA, IgG, IgM, Complement C3, Complement C4, a1-Antitrypsin, and Transferrin on automated, semi-automated, and manual chemistry systems",
    "fda_folder": "Clinical Chemistry"
}